會員登入
註冊
【Intro】Cyclica Inc
2021-07-12 / 新聞中心
CompanyIntroductionCyclicaisthepartnerofchoicefordata-drivendrugdiscovery.Weadvancemoleculesthatembracethecomplexityofdisease.Ourworkspansdozensofcollaborationswithlargepharmaandbiotechaswellas50joint...
【Intro】Skinopathy
2021-07-12 / 新聞中心
CompanyIntroductionSkinopathyIncisamedicaltechnologycompanycreatingArtificialIntelligence,AugmentedReality,andautomationtechnologythatwillofferthepublicandmedicalcommunitystate-of-the-artskindiseasemi...
【Intro】Single Cell Technology, Inc.
2021-07-12 / 新聞中心
CompanyIntroductionSingleCellTechnology(SCT)wasestablishedin2008.WenamedourantibodydiscoverytechnologyaftertheGreekwordatheneum,meaninganinstituteforscientificlearning.AbTheneum™technologywasind...
【Intro】Taiwania Capital Management Corporation
2021-07-12 / 新聞中心
CompanyIntroductionTaiwaniaCapitalisaventurecapitalfirmthatwasfoundedin2017bytheNationalDevelopmentFundoftheExecutiveYuanofTaiwanandprivateenterprises.Ourmissionistoestablishapartnershipwithcompaniesw...
【Intro】Bay Area Health Trust
2021-07-12 / 新聞中心
CompanyIntroductionBayAreaHealthTrustisaHamilton,Ontario-basedcompanythatoperateslifesciencebusinessestoreturnvaluetoitsbeneficiaries,includingHamiltonHealthSciencesandMcMasterUniversity.Asauniqueorga...
【Intro】DCI Partners Co., Ltd.
2021-07-12 / 新聞中心
CompanyIntroductionDCIPartnersisaJapan-basedlifescienceventurecapitalfirmfocusedoninvestmentsinthepharmaceutical, biotechnologyand medicaldeviceindustries.Briefdescriptionofmainproductsorservices Mana...
【Intro】LuminX Biotech Co., Ltd
2021-07-12 / 新聞中心
CompanyIntroductionLuminXBiotechdedicatestoacceleratetheoptimizationofcell-therapy-productsthroughspecificunderstandingoftherapeuticcellsdistributionin-vivo,long-termviability,aswellastheirbiologicalf...
【Intro】cytena Bioprocess Solution co., Ltd - Cellink Group
2021-07-12 / 新聞中心
CompanyIntroductioncytenaBioprocessSolutionco.,Ltd(cBS)isfoundedin2018andisasubsidiaryofalistedSweden3DprintingcompanyCellinkAB.cytenaBioprocessSolutionsfocusesonofferingbioprocesssolutionsfor,butnotl...
【Intro】C4U CORPORATION
2021-07-12 / 新聞中心
CompanyIntroductionC4UCorporationisabiotechnologyventurecompanyfoundedinMay2018,byDr.TomojiMashimo(currentlyProfessorofUniversityofTokyo)etal.Wehavedevelopedproprietarygeneeditingtechniquessuchasoneus...
【Intro】Momotaro-Gene Inc.
2021-07-12 / 新聞中心
CompanyIntroductionMomotaro-GeneInc.isacancergenetherapycompany.WeareusingREIC/Dkk-3geneisolatedatOkayamaUniversity.OurAdenovirusvectorcarryingREIC(Ad-REIC)showsagreatpromisetocurethesolidtumor.Briefd...
【Intro】Antaimmu BioMed Co., Ltd.
2021-07-12 / 新聞中心
CompanyIntroduction主要開發新一代免疫治療生物藥劑Neobody™，透過對癌細胞的高度專一標靶作用、增強免疫檢查點阻斷功能、並避免對正常細胞的攻擊而減少副作用，達到提高整體免疫系統對癌細胞的偵測以及毒殺作用。安肽生醫目前已經開發了噬菌體展示平台(phagedisplayplatform)，表現人類合成抗體庫、原生性抗體庫、以及免疫小鼠的抗體庫，可用於篩選對癌症標靶分子...
【Intro】Steminent Biotherapeutics Inc.
2021-07-12 / 新聞中心
CompanyIntroduction仲恩生醫專注於脂肪間葉幹細胞(Adipose-DerivedMesenchymalStemCells,AD-MSCs)藥物化技術平台之開發，發展針對不治及難治之症的幹細胞藥物。仲恩生醫具備獨特處裡技術，為亞洲第一個進入台、日、美臨床二期試驗階段的幹細胞生技新藥公司，並同時取得治療小腦萎縮症的美國及日本孤兒藥資格（日本由授權合作伙伴取得孤兒藥資格）。台灣小腦萎縮...
